Potential of Copper and Copper Compounds for Anticancer Applications

Peng Ji, Peng Wang, Hao Chen, Yajing Xu, Jianwen Ge, Zechong Tian, Zhirong YanPharmaceuticals 2023 · DOI

TL;DR

This review explores the exciting potential of copper and its compounds as anticancer agents. By understanding the diverse ways copper can induce cancer cell death, researchers are developing novel therapeutic strategies with fewer side effects and improved efficacy compared to traditional treatments.

What Problem Does This Paper Address?

Traditional cancer treatments like surgery, chemotherapy, and radiotherapy, while effective, often come with significant side effects and limitations, particularly due to the unique characteristics of cancer cells (immortal proliferation, transformation, and metastasis). This has driven the search for more targeted and less toxic therapeutic approaches. The paper addresses the growing interest in using metal elements, specifically copper, as a promising avenue for cancer therapy by inducing various forms of programmed cell death in cancer cells.

Methods

This paper is a review article, so it doesn't present novel experimental methods. Instead, it synthesizes and analyzes existing research on copper's role in cancer therapy. The "methods" discussed within the review refer to the various mechanisms by which copper and its compounds induce cancer cell death. These include:

  • Activation of Stress Pathways: Inducing endoplasmic reticulum stress and oxidative stress.
  • Cell Cycle Arrest: Halting the progression of cancer cell division.
  • Inhibition of Angiogenesis: Preventing the formation of new blood vessels that feed tumors.
  • Cuproptosis: A newly identified copper-dependent cell death pathway linked to mitochondrial respiration.
  • Paraptosis: A non-apoptotic programmed cell death pathway.

The review also discusses the synthesis and evaluation of various copper complexes and nanomaterials designed to exploit these mechanisms.

Datasets

Not discussed in the paper.

Key Insights and Ideas

  • Copper's Dual Nature: Copper is an essential trace element for human health, but its dysregulation, particularly overload, can be cytotoxic, making it a potential anticancer agent.
  • Diverse Cell Death Mechanisms: Copper doesn't rely on a single mode of action; it can trigger apoptosis, autophagy, cuproptosis, and paraptosis, offering multiple avenues to combat cancer.
  • Targeted Delivery is Key: The challenge lies in delivering copper specifically to tumor cells while minimizing harm to healthy tissues, highlighting the importance of novel copper complexes and nanocarriers.
  • Cuproptosis: A New Frontier: The recent discovery of cuproptosis, a distinct copper-dependent cell death pathway, opens up exciting new possibilities for cancer treatment.
  • Synergistic Potential: Copper compounds can enhance the efficacy of existing therapies and may be combined with other treatment modalities for improved outcomes.

Key Results

The paper highlights numerous studies demonstrating the efficacy of copper and its complexes in various cancer models. While specific quantitative results are scattered across the cited literature, the review emphasizes:

  • Significant Cytotoxicity: Many copper complexes show potent cytotoxicity against a range of cancer cell lines, often with lower toxicity to normal cells.
  • Tumor Growth Inhibition: In vivo studies using copper-based agents have demonstrated significant reduction in tumor volume and improved survival rates in animal models.
  • Mechanism Validation: The review details how various copper compounds have been shown to activate specific stress pathways, arrest cell cycles, inhibit angiogenesis, and induce cuproptosis and paraptosis, validating these mechanisms of action.

Limitations and Future Work

The authors acknowledge several limitations and suggest future directions:

  • Unclear Mechanisms: While several mechanisms of copper-induced cell death are known, many are still being explored and require further in-depth research.
  • Biocompatibility and Safety: The biocompatibility and safety of novel copper complexes need rigorous evaluation to ensure they are effective and well-tolerated.
  • Targeted Delivery: Accurately delivering copper to tumor cells while sparing healthy tissues remains a significant challenge. The development of multifunctional, targeted, and intelligent copper nano-formulations is crucial.
  • Early Detection: The late diagnosis of many cancers necessitates further research into copper's role in early detection and treatment.
  • Dual Diagnosis and Treatment: The integration of copper with diagnostic nanoparticles for combined diagnosis and treatment functions is a promising area for future development.

Summary updated

Abstract

Inducing cancer cell death has always been a research hotspot in life sciences. With the continuous deepening and diversification of related research, the potential value of metal elements in inducing cell death has been explored. Taking iron as an example, ferroptosis, mainly characterized by increasing iron load and driving the production of large amounts of lipid peroxides and eventually leading to cell death, has recently attracted great interest in the cancer research community. After iron, copper, a trace element, has received extensive attention in cell death, especially in inducing tumor cell death. Copper and its complexes can induce autophagy or apoptosis in tumor cells through a variety of different mechanisms of action (activation of stress pathways, arrest of cell cycle, inhibition of angiogenesis, cuproptosis, and paraptosis), which are promising in cancer therapy and have become new hotspots in cancer treatment research. This article reviews the main mechanisms and potential applications of novel copper and copper compound-induced cell death, focusing on copper compounds and their anticancer applications.
BibTeX
@inproceedings{ji2023potential,
  author = {Peng Ji and Peng Wang and Hao Chen and Yajing Xu and Jianwen Ge and Zechong Tian and Zhirong Yan},
  title = {{Potential of Copper and Copper Compounds for Anticancer Applications}},
  booktitle = {Pharmaceuticals},
  year = {2023},
  doi = {10.3390/ph16020234},
}
Figure